HiberCell Announces Successful Completion and Interim : vima

HiberCell Announces Successful Completion and Interim Results of Phase 1 Study of HC-5404 and Maps Forward Path as Monotherapy and in Combinations...

Related Keywords

Jonathan Lanfear , Clinical Cancer Research , Albert Einstein College Of Medicine , Renal Cell Carcinoma , Kinase Inhibitors , Clinical Cancer , Einstein College , Albert Einstein College , Unfolded Protein Response , Hibercell , Nc ,